The prostaglandin H2 analog U-46619 improves the differentiation efficiency of human induced pluripotent stem cells into endothelial cells by activating both p38MAPK and ERK1/2 signaling pathways
- Stem Cell Res Ther. 2018 Nov 15;9(1):313. doi: 10.1186/s13287-018-1061-4.
- 1. National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, 117609, Singapore.
- 2. Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, China.
- 3. Department of Cardiology, National University Health System Singapore and Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- 4. Stem cell Institute, University of Minnesota, Minneapolis, MN, USA.
- 5. Institute of Medical Biology, A*STAR, Singapore, Singapore.
- 6. Programme in Cardiovascular & Metabolic Disorders, Duke-National University of Singapore, Singapore, Singapore.
- 7. NHLI, Imperial College, London, UK.
- 8. Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, China. [email protected].
- 9. Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, AL, 35294-2182, USA. [email protected].
- 10. National Heart Research Institute of Singapore, National Heart Centre Singapore, Singapore, 117609, Singapore. [email protected].
Background: We have shown that the differentiation of human-induced pluripotent stem cells (hiPSCs) into endothelial cells (ECs) is more efficient when performed with a 3-dimensional (3D) scaffold of biomaterial than in monolayers. The current study aims to further increase hiPSC-EC differentiation efficiency by deciphering the signaling pathways in 3D scaffolds.
Methods and results: We modified our 3D protocol by using U-46619 to upregulate both p38 mitogen-activated protein kinase (p38MAPK) and extracellular signal-regulated kinase 1/2 (ERK1/2) signaling, which increased the differentiation efficiency (as measured by CD31 expression) to as high as 89% in two established hiPSC lines. The differentiated cells expressed arteriovenous, but not lymphatic, markers; formed tubular structures and EC lumen in vitro; had significantly shorter population-doubling times than monolayer-differentiated hiPSC-ECs; and restored perfusion and vascularity in a murine hind limb ischemia model. The differentiation efficiency was also > 85% in three hiPSC lines that had been derived from patients with diseases or disease symptoms that have been linked to endothelial dysfunction.
Conclusions: These observations demonstrate that activating both p38MAPK and ERK1/2 signaling pathways with U-46619 improves the efficiency of arteriovenous hiPSC-EC differentiation and produces cells with greater proliferative capacity.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Prostaglandin ReceptorResearch Areas: Cardiovascular Disease